Sign in
RARE Stock Price, Chart, Stats & News
Ultragenyx Pharmaceutical Inc.
Save
2.88B
Market cap
–
Current P/E
–
Forward P/E
RARE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 83.85% |
Operating margin | -79.63% |
Pretax margin | -84.93% |
Net margin | -85.54% |
Effective tax rate | -0.72% |
ROA | -37.56% |
ROE | -1024.42% |
D/E | -15.95x |
Interest coverage ratio | -8.71x |
RARE valuation
P/E | – |
P/S | 2.78x |
P/B | -24.20x |
P/CF | -4.15x |
P/FCF | -3.97x |
P/OCF | -4.15x |
PEG | -2.00x |
EV multiple | -2.15x |
About
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative treatments for rare and ultra-rare genetic conditions. Its operations span North America, Europe, and other international markets. The company's portfolio of marketed biologic products addresses several serious diseases.
Similar securities
Based on sector and market capitalization
Report issue